SHRIRAMPPS2023-04-012023-06-30 SHRIRAMPPS2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member SHRIRAMPPS2023-04-012023-06-30in-bse-fin:OneOperatingExpenses02Member SHRIRAMPPS2023-06-30 SHRIRAMPPS2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543419 SHRIRAMPPS NA Shriram Properties Limited Equity 2023-04-01 2024-03-31 2023-08-14 2023-08-08 INR Millions First quarter 12:30:00 13:45:00 2023-08-14 2023-08-14 Not applicable Single segment Real Estate 2023-04-01 2023-06-30 Unaudited Standalone 305950000.00 190670000.00 496620000.00 30170000.00 0.00 52120000.00 161670000.00 93560000.00 8350000.00 107990000.00 453860000.00 42760000.00 0.00 42760000.00 0.00 8400000.00 8400000.00 0.00 34360000.00 0.00 0.00 0.00 0.00 34360000.00 -880000.00 33480000.00 33480000.00 0.00 1700180000.00 10 0.20 0.20 0.00 0.00 0.20 0.20 1. The above Standalone Financial Results of Shriram Properties Limited ( the Company ), for the quarter ended 30 June 2023 have been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards ('Ind AS ) as prescribed under section 133 of the Companies Act 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 as amended, and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. 2. These Standalone Financial Results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 14 August 2023. 3. During the quarter ended 30 June 2023, the Company has fully utilized the IPO proceeds towards the objects of the issue as per the prospectus. 4. The Company is primarily engaged in the business of real estate development, which is considered to be the only reportable segment by the management. Further, the operations of the Company is domiciled in India and therefore there are no reportable geographical segment. Impairment losses 30000.00 Other expenses 107960000.00 Re-measurement loss on defined benefit plans -880000.00 -880000.00 0.00 0.00